United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $834,836,763.10
Most recent insider trade:
  • April 17, 2025
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
March 26, 2020Director5,000$91.75Sell$458,750.00
June 27, 2019Director3,750$76.11Sell$285,412.50
June 20, 2019Director5,000$79.05Sell$395,250.00
March 7, 2019Director3,370$110.75Sell$373,227.50
Feb. 5, 2019Director400$117.00Sell$46,800.00
Jan. 30, 2019CEO14,108$115.77Sell$1,633,283.16
Jan. 28, 2019CEO14,108$115.37Sell$1,627,639.96
Jan. 24, 2019CEO7,054$113.95Sell$803,803.30
Jan. 22, 2019CEO7,054$113.35Sell$799,570.90
Jan. 17, 2019CEO14,108$113.70Sell$1,604,079.60
Jan. 15, 2019CEO14,108$114.85Sell$1,620,303.80
Jan. 10, 2019CEO14,108$113.51Sell$1,601,399.08
Jan. 8, 2019CEO7,054$113.16Sell$798,230.64
Jan. 4, 2019CEO7,055$111.51Sell$786,703.05
Sept. 10, 2018Director810$119.00Sell$96,390.00
Sept. 6, 2018Director810$118.00Sell$95,580.00
Aug. 16, 2018Director3,240$129.38Sell$419,191.20
Aug. 3, 2018Director580$127.48Sell$73,938.40
June 29, 2018Director3,240$113.07Sell$366,346.80
June 12, 2018Director600$112.38Sell$67,428.00
April 9, 2018CEO21,513$110.88Sell$2,385,361.44
April 5, 2018CEO21,512$114.30Sell$2,458,821.60
April 3, 2018CEO22,059$114.44Sell$2,524,431.96
March 29, 2018CEO43,024$111.14Sell$4,781,687.36
March 22, 2018CEO1,100$110.01Sell$121,011.00
March 20, 2018CEO301$110.48Sell$33,254.48
March 16, 2018CEO43,025$111.11Sell$4,780,507.75
March 14, 2018CEO21,512$112.55Sell$2,421,175.60
Dec. 8, 2017CEO1$136.16Sell$136.16
Dec. 7, 2017Director580$134.72Sell$78,137.60
Nov. 30, 2017CEO1,241$128.95Sell$160,026.95
Nov. 24, 2017CEO1,253$124.07Sell$155,459.71
Nov. 16, 2017CEO7,061$121.12Sell$855,228.32
Nov. 9, 2017CEO1,260$121.46Sell$153,039.60
Nov. 6, 2017Director580$122.00Sell$70,760.00
Nov. 2, 2017CEO1,269$118.04Sell$149,792.76
Oct. 26, 2017CEO1,263$120.38Sell$152,039.94
Oct. 19, 2017CEO1,265$119.38Sell$151,015.70
Oct. 12, 2017CEO1,263$120.20Sell$151,812.60
Oct. 5, 2017CEO1,256$122.98Sell$154,462.88
Oct. 5, 2017Director580$122.00Sell$70,760.00
Sept. 28, 2017CEO1,265$119.70Sell$151,420.50
Sept. 21, 2017CEO1,274$116.07Sell$147,873.18
Sept. 14, 2017CEO1,258$122.08Sell$153,576.64
Sept. 7, 2017CEO1,232$133.32Sell$164,250.24
Sept. 7, 2017Director580$134.48Sell$77,998.40
Aug. 31, 2017CEO1,235$130.49Sell$161,155.15
Aug. 24, 2017CEO1,238$130.65Sell$161,744.70
Aug. 17, 2017CEO1,235$131.95Sell$162,958.25
Aug. 10, 2017CEO2,176$127.11Sell$276,591.36
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.